Download ![]() |
< Back |
08 Aug 2022 | |
With reference to the captioned subject, this is to inform the exchange that the Company's wholly owned subsidiary, Aleor Dermaceuticals Limited has received US Food and Drug Administration (USFDA) Final Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%. Please find enclosed herewith our press release. We request you to kindly take the same on record. | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |